CVS Health (CVS) Tops Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads gains as SpaceX, Super Micro results improve AI appetite
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $94.28 -0.5%
Revenue Growth %: +1.8%
Financial Fact:
Interest expense, net: 253M
Today's EPS Names:
OMID, BCML, CZNC, More
Revenue Growth %: +1.8%
Financial Fact:
Interest expense, net: 253M
Today's EPS Names:
OMID, BCML, CZNC, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q2 EPS of $1.33, $0.02 better than the analyst estimate of $1.31. Revenue for the quarter came in at $45.7 billion versus the consensus estimate of $45.37 billion.
Comps decline 2.6%
GUIDANCE:
CVS Health sees FY2017 EPS of $5.83-$5.93, versus the consensus of $5.87.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix shares fall over 5% premarket on soft current-quarter revenue guidance
- Philip Morris beats estimates but shares slip on cost pressures
- Danaher (DHR) Tops Q3 EPS by 19c, Beats on Revenue; Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot Guidance, Retail SalesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
